Primary Combined Hepatocellular-Cholangiocarcinoma: A Case of Underdiagnosed Primary Liver Cancer

被引：3

作者：

Ayas, Mohamad F. ^{[1
]}

Affas, Saif ^{[1
]}

Ayas, Zayd ^{[2
]}

Chand, Momal ^{[3
]}

Hadid, Tarik ^{[4
]}

机构：

[1] Ascension St John Hosp, Internal Med, Detroit, MI 48236 USA

[2] Univ Texas Austin, Coll Nat Sci, Basic Sci, Austin, TX 78712 USA

[3] Ascension St John Hosp, Pathol, Detroit, MI USA

[4] Ascension St John Hosp, Oncol, Detroit, MI USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2021年 / 13卷 / 09期

关键词：

hepatocellular carcinoma (hcc); cholangiocarcinoma; combined hepatocellular-cholangiocarcinoma; trans-arterial radioembolization; liver tumor; CARCINOMA; TRANSPLANTATION; FEATURES; OUTCOMES;

D O I：

10.7759/cureus.18224

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Combined hepatocellular-cholangiocarcinoma (CHC) is a rare primary tumor of the liver. Histologically, it comprises components of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) but is associated with a worse prognosis. International guidelines regarding its management are scarce, with surgical management (major hepatectomy) being the treatment of choice. In this report, we present a challenging case of a 73-year-old male with primary CHC who was not a surgical candidate but underwent hepatic artery radioembolization instead.

引用

页数：6

共 50 条

[1] Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers
Lee, Chern-Horng
Hsieh, Sen-Yung
Chang, Chee-Jen
Lin, Yu-Jr
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (01) : 122 - 127
[2] Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series
De Vito, Claudio
Sarker, Debashis
Ross, Paul
Heaton, Nigel
Quaglia, Alberto
VIRCHOWS ARCHIV, 2017, 471 (05) : 619 - 629
[3] Combined Hepatocellular-Cholangiocarcinoma: A Population-Level Analysis of an Uncommon Primary Liver Tumor
Garancini, Mattia
Goffredo, Paolo
Pagni, Fabio
Romano, Fabrizio
Roman, Sanziana
Sosa, Julie Ann
Giardini, Vittorio
LIVER TRANSPLANTATION, 2014, 20 (08) : 952 - 959
[4] Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma
Satake, Tomoyuki
Shibuki, Taro
Watanabe, Kazuo
Sasaki, Mitsuhito
Imaoka, Hiroshi
Mitsunaga, Shuichi
Kojima, Motohiro
Ikeda, Masafumi
FRONTIERS IN ONCOLOGY, 2023, 13
[5] Combined hepatocellular-cholangiocarcinoma: An update
Reig, Maria
Cabibbo, Giuseppe
JOURNAL OF HEPATOLOGY, 2021, 74 (05) : 1225 - 1233
[6] HEPATITIS-C VIRUS-ANTIBODY IN PATIENTS WITH PRIMARY LIVER-CANCER (HEPATOCELLULAR-CARCINOMA, CHOLANGIOCARCINOMA, AND COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA) IN JAPAN
TOMIMATSU, M
ISHIGURO, N
TANIAI, M
OKUDA, H
SAITO, A
OBATA, H
YAMAMOTO, M
TAKASAKI, K
NAKANO, M
CANCER, 1993, 72 (03) : 683 - 688
[7] Pathology of combined hepatocellular-cholangiocarcinoma
Yeh, Matthew M.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (09) : 1485 - 1492
[8] Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series
Claudio De Vito
Debashis Sarker
Paul Ross
Nigel Heaton
Alberto Quaglia
Virchows Archiv, 2017, 471 : 619 - 629
[9] Combined hepatocellular-cholangiocarcinoma with angiosarcomatoid change: A case report with immunohistochemical study
Hakozaki, Mayu
Ito, Shinji
Fujii, Takeshi
Kiya, Yoshitaka
Udagawa, Harushi
Fukayama, Masashi
Fukusato, Toshio
PATHOLOGY INTERNATIONAL, 2019, 69 (02) : 110 - 116
[10] The Diagnostic Conundrum and Liver Transplantation Outcome for Combined Hepatocellular-Cholangiocarcinoma
Panjala, C.
Senecal, D. L.
Bridges, M. D.
Kim, G. P.
Nakhleh, R. E.
Nguyen, J. H. H.
Harnois, D. M.
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1263 - 1267

← 1 2 3 4 5 →